Pricing

Log inSign up

Attralus Therapeutics

30 people · 0 jobs
‌

Attralus is a clinical stage biopharmaceutical company focused on creating transformative medicines to improve the lives of patients with systemic amyloidosis.

Industries

Biotechnology

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Mark Timney
CEO
Collapse
Spencer Guthrie
Co-Founder & COO
Glen Firestone
Chief Business Officer
Gregory Bell
Chief Medical Officer
Jonathan Wall
Co-Founder & Interim Chief Scientific Officer
James Testa
VP, Finance
Lesley Davis
Director Of Quality
Andy Vick
Vice President, Head Of Toxicology, Drug Disposition, And Pk/pd
Nicolas Angell
Vice President CMC

Board & advisors

Richard Gaster
Board Member
Rahul Kakkar
Board Member
Corey Goodman
Board Member
Nancy Miller-Rich
Board Member
Jake Bauer
Board Member
Alexander Denner
Board Member
Jaume Pons
Scientific Advisor
Jeff Kelly
Scientific Advisor
Morie Gertz
Scientific Advisor
Mathew Maurer
Scientific Advisor

Teams

+7

Regulatory and Scientific Development

11 people · 0 jobs

Clinical Operations and Development

3 people · 0 jobs

+2

Leadership Team

6 people · 0 jobs

Offices

Similar companies

Tango Therapeutics

3 followers

Cellares

4 followers

Gilead Sciences

161 followers

Regeneron

133 followers

Illumina

79 followers

Agilent Technologies

85 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

45 followers

GRAIL

29 followers

Cytiva

18 followers

PerkinElmer

12 followers

Explore companies